Novartis advances with push on cancer and liver disease
April 18, 2017 at 04:07 AM EDT
ZURICH, April 18 (Reuters) - Novartis's push into oncology and liver disease, two of its treatment priorities, advanced on Monday as the Swiss drugmaker won a second U.S. breakthrough tag for its cancer gene therapy while striking a separate pact with Allergan.